fDi Markets Newswire:

the brains

The brains behind Kaunas's rise

Kaunas has established a reputation as a medical technology and R&D hub for the Baltic region. Its next step, as Natasha Turak discovers, is to ensure that its technological prowess is acknowledged on a global scale.

Lexington Medical

Massachusetts meets Lexington Medical’s needs

Lexington Medical’s expansion highlights its optimism about the wealth of expertise in the medical device industry in Massachusetts, as the locally incubated company opens a headquarters in the state. Natasha Turak reports.

Beyond biotech

Cologne’s BioCampus extends its remit to other disciplines

Cologne's biotech centre BioCampus is branching out from its original purpose. Director André van Hall tells Natasha Turak why an interdisciplinary approach is the way forward.

Ute Berg

Tech-driven companies central to Cologne's future

Ute Berg, general manager of BioCampus Cologne and deputy mayor for economic development and real estate, explains to fDi how innovation and technology are vital for the future prosperity of the city.

GlaxoSmithKline in Upper Providence

Worth the experiment? US second-tier biotech locations make their case

Soaring costs at the US's major biotech hubs such as Boston and California are moving the spotlight to second-tier locations. But how can the likes of Philadelphia, Minneapolis and Maryland stand out from the crowd at attract investment in this lucrative sector? Michal Kaczmarski finds out.

Biocartis-finds-comfort-in-its-Belgian-base

Biocartis finds comfort in its Belgian base

The decision to move molecular diagnostics company Biocartis from Eindhoven to the small Belgian city of Mechelen could be viewed as a nostalgic one by the firm's Belgian founder, Rudi Pauwels. However, the location's tax incentives and grants have gone some way towards helping the firm to prepare for an international expansion. 

View-from-Bio-2015-what-the-representatives-said

View from Bio 2015: what the representatives said

The Bio International Convention in Philadelphia attracted thousands of visitors from the world of biotech. Michal Kaczmarski spoke to representatives from a number of locations keen to catch the attention of would-be investors in this lucrative field to find out what makes their country stand out.

Thailand pharma

Thailand's new lease of life

Thailand's expertise in the life sciences sector has long remained under the radar, with a lack of investment preventing many of the discoveries from its scientific community making it to the commercial stage. But a government entity, the Thailand Centre for Excellence for Life Sciences, is looking to change this.

biopharma

Biotech-pharma hotspots on the up

Locations are taking advantage of the growing demand for healthcare, bringing together academia, big industry, start-ups, hospitals and sources of capital to create thriving specialised biomedical-pharmaceutical clusters.

Think Tank

Think Tank: how to stay one step ahead of an outbreak

Building an innovation culture can help countries prepare for the outbreak of diseases such as Ebola, write Rachel Chu and Meir Pugatch of Pugatch Consilium.

fDi Tools

fDi Intelligence has a portfolio of related products that enable you to get the targeted foreign investment information you need for your role: 

fdimarkets

For real-time crossborder greenfield investment data on all sectors and locations, click here

fdibenchmark

To benchmark locations for investment projects, click here

fdireports

For bespoke reports on companies, locations or sectors, click here

By continuing to use this site you consent to the use of cookies on your device as described in our cookie policy unless you have disabled them. You can change your cookie settings at any time but parts of our site will not function correctly without them.